CAS:879085-55-9   2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide
CAS:879085-55-9   2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide
+
  • CAS:879085-55-9   2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide
  • CAS:879085-55-9   2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide

CAS:879085-55-9 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide

NAME:2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide CAS:879085-55-9 MF:C19H14Cl2N2O3S MW:421.3 PURITY:98%

Categories:

Material Chemistry

Product introduction

NAME 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide
CAS 879085-55-9
MF C19H14Cl2N2O3S
MW 421.3
DENSITY 1.440
EINECS 806-752-3
MP 179-181°C
BP 561.6±50.0 °C
STORAGE -20° 

Description
Vismodegib, sold under the brand name Erivedge, is a medication used for the treatment of basal-cell carcinoma (BCC). It was approved by the U.S. Food and Drug Administration (FDA) on January 30, 2012, representing the first Hedgehog signaling pathway targeting agent to gain FDA approval 

Key words:

Related Products

Related Products

Inquiry

SUBMIT